emamectin-benzoate and Parasitic-Diseases--Animal

The effect of 0.2% emamectin benzoate (SLICE; Intervet/ Schering-Plough Animal Health, Roseland, New Jersey) administered in top-dressed, pelleted commercial fish feed was evaluated for control of freshwater Argulus sp. in goldfish Carassius auratus and koi carp, a variant of common carp Cyprinus carpio, in freshwater aquaria at 24-25 degrees C. Sixteen individually housed goldfish were each exposed to 37 Argulus. The number of fish lice attached to each fish at the start of the experiment was not determined; however, the total number of motile fish lice in each aquarium (on fish and in the water) was determined at the start and end of each experiment. Eight goldfish were fed the control diet (0 microg x kg fish biomass(-1) x d(-1)) and eight were fed the medicated diet (50 microg x kg fish biomass(-1) x d(-1)) for seven consecutive days. After treatment, fish louse infestation in controls was 20.5 +/- 1.5 (mean +/- SE) lice per fish. No Argulus were found on fish in the treated group. In a separate experiment, 10 individually housed koi were each exposed to 128 Argulus. Five koi were fed the control diet and five were fed a low-dose medicated diet (5 microg x kg fish biomass(-1) x d(-1)) for 7 d. After treatment, fish louse infestation among the controls was 14.6 +/- 3.8 lice per koi. No Argulus were found on koi in the treated group. Hence, a 7-d regimen of oral emamectin benzoate controlled experimental infestation of Argulus when administered to goldfish at 50 microg x kg fish biomass(-1) x d(-1) and to koi at 5 microg x kg fish biomass(-1) x d(-1).

Topics: Animals; Antiparasitic Agents; Arguloida; Carps; Fish Diseases; Ivermectin; Parasitic Diseases, Animal

Topics: Animals; Antiparasitic Agents; Copepoda; Fish Diseases; Fisheries; Ivermectin; Linear Models; Parasitic Diseases, Animal; Population Density; Salmo salar; Scotland; Treatment Outcome

Efficacy of in-feed treatment with emamectin benzoate (Slice) for the control of ectoparasitic Argulus coregoni on rainbow trout Oncorhynchus mykiss was tested under laboratory and field conditions. In both experiments fish were fed with fish feed to deliver a therapeutic dose of 0 (control) or 50 microg emamectin benzoate kg(-1) d(-1) (treatment) for a period of 7 d. After 3 d of challenge with A. coregoni in the laboratory, the infestation level in treated fish was lower than that observed in the controls (p < 0.001). Efficacy of 100% against newly hatched A. coregoni metanauplii and adults and 80% against juveniles was observed. In the field, trial medication was undertaken at 2 sections on a flow-through canal with 1 wk between treatments. Mean infestations of 100 to 200 A. coregoni per fish with 100% prevalence was recorded prior to medication. Following the treatment, the mean infestation of A. coregoni on fish declined to 31 lice per fish at Section A and 2.5 lice per fish at Section B. Then, after 28 d of treatment, the number of lice per fish was < 1 at Section A; in contrast the mean number of A. coregoni per fish at the control section was > 20. The prevalence of A. coregoni remained < 50% over a period of 72 d of treatment, but started to increase again thereafter. This suggests that emamectin benzoate concentration in fish remained at a level high enough to kill A. coregoni over a period of 9 wk. Emamectin benzoate was very effective in the control of A. coregoni infesting trout.

Topics: Animals; Aquaculture; Arguloida; Finland; Fish Diseases; Ivermectin; Oncorhynchus mykiss; Parasitic Diseases, Animal; Time Factors